Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients.
Ventero MP, Moreno-Perez O, Molina-Pardines C, Paytuví-Gallart A, Boix V, Escribano I, Galan I, González-delaAleja P, López-Pérez M, Sánchez-Martínez R, Merino E, Rodríguez JC.
Ventero MP, et al. Among authors: merino e.
J Infect. 2022 Mar;84(3):329-336. doi: 10.1016/j.jinf.2021.12.030. Epub 2021 Dec 25.
J Infect. 2022.
PMID: 34963638
Free PMC article.